IP Library Granted Patent US 7,935,731
Granted Patent B2
US 7,935,731 · App. 12/786,921 · Granted May 3, 2011

Methods for concomitant administration of colchicine and macrolide antibiotics

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,935,731
App. No.
12/786,921
Granted
May 3, 2011
Kind
B2
Abstract

Methods for concomitant administration of colchicine together with one or more macrolide antibiotics, e.g., clarithromycin, are disclosed. Such methods reduce the dangers commonly associated with such concomitant administration and provide additional benefits.

Claims (16)

1. A method of using colchicine for the treatment of Familial Mediterranean Fever in a human patient in need of treatment thereof, said method comprising:

orally administering a reduced colchicine dosage amount to the human patient in need of treatment for Familial Mediterranean Fever who is concomitantly receiving administration of clarithromycin within 1 to 2 days of oral administration of colchicine, wherein the reduced colchicine dosage amount is reduced compared to a daily dosage amount to be administered in the absence of concomitant clarithromycin and is about 0.3 mg of colchicine twice per day, wherein the daily dosage amount of colchicine in the absence of concomitant clarithromycin is:

Daily dosage amount

Age

Usual

Maximum

Adults and children >12 years

1.2 mg

2.4 mg

Children >6 to 12 years

0.9 mg

1.8 mg

Children 4 to 6 years

0.3 mg

1.8 mg

and wherein the dose of clarithromycin is 250 mg twice per day.

Assignments (6)
MERGER Recorded Nov 30, 2012
From: AR HOLDING COMPANY, INC.
To: MPC OLDCO, INC.
Reel/Frame 029378/0850 →
MERGER Recorded Nov 30, 2012
From: MPC OLDCO, INC.
To: MPC MERGER SUB, INC.
Reel/Frame 029380/0671 →
MERGER Recorded Nov 30, 2012
From: MPC MERGER SUB, INC.
To: TAKEDA PHARMACEUTICALS U.S.A., INC.
Reel/Frame 029380/0855 →
RELEASE OF SECURITY INTEREST Recorded Aug 4, 2011
From: UBS AG, STAMFORD BRANCH, A SWISS BANKING INSTITUTION
To: MUTUAL PHARMACEUTICAL COMPANY, INC., A PENNSYLVANIA CORPORATION
Reel/Frame 026700/0882 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2011
From: MUTUAL PHARMACEUTICAL COMPANY, INC.
To: AR HOLDING COMPANY, INC.
Reel/Frame 026261/0141 →
SECURITY AGREEMENT Recorded Jul 13, 2010
From: MUTUAL PHARMACEUTICAL COMPANY, INC., A PENNSYLVANIA CORPORATION
To: UBS AG, STAMFORD BRANCH
Reel/Frame 024672/0325 →